| Autor: |
Pagani I; IRCCS San Raffaele Scientific Institute, Milano, Italy., Venturini A; Telethon Institute of Genetics and Medicine, Pozzuoli, NA, Italy., Capurro V; Istituto Giannina Gaslini Istituto Pediatrico di Ricovero e Cura a Carattere Scientifico, Genova, Liguria, Italy., Nonis A; Vita-Salute San Raffaele University, University Center for Statistics in the Biomedical Sciences (CUSSB), Milano, Italy., Ghezzi S; IRCCS San Raffaele Scientific Institute, Milano, Italy., Lena M; Istituto Giannina Gaslini Istituto Pediatrico di Ricovero e Cura a Carattere Scientifico, Genova, Liguria, Italy., Alcalá-Franco B; IRCCS San Raffaele Scientific Institute, Milano, Italy., Gianferro F; IRCCS San Raffaele Scientific Institute, Milano, Italy., Guidone D; Telethon Institute of Genetics and Medicine, Pozzuoli, NA, Italy., Colombo C; Ospedale Maggiore Policlinico, Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda, Milano, Italy., Pedemonte N; Istituto Giannina Gaslini Istituto Pediatrico di Ricovero e Cura a Carattere Scientifico, Genova, Liguria, Italy., Bragonzi A; IRCCS San Raffaele Scientific Institute, Milano, Italy., Cigana C; IRCCS San Raffaele Scientific Institute, Milano, Italy., Galietta LJV; Telethon Institute of Genetics and Medicine, Pozzuoli, A, Italy., Vicenzi E; IRCCS San Raffaele Scientific Institute, Milano, Italy; vicenzi.elisa@hsr.it. |
| Abstrakt: |
The COVID-19 pandemic has underscored the impact of viral infections on individuals with cystic fibrosis (CF). Initial observations suggested lower COVID-19 rates among CF populations; however, subsequent clinical data have presented a more complex scenario. This study aimed to investigate how bronchial epithelial cells from CF and non-CF individuals, including various CF transmembrane conductance regulator (CFTR) mutations, respond to in vitro infection with SARS-CoV-2 variants and SARS-CoV. Comparisons with the Influenza A virus (IAV) were included based on evidence that CF patients experience heightened morbidity from IAV infection. Our findings showed that CF epithelial cells exhibited reduced replication of SARS-CoV-2, regardless of the type of CFTR mutation or SARS-CoV-2 variant, as well as the original 2003 SARS-Cove. In contrast, these cells displayed more efficient IAV replication compared to non-CF cells. Interestingly, the reduced susceptibility to SARS-CoV-2 in CF was not linked to the expression of angiotensin converting enzyme 2 (ACE2) receptor nor to CFTR dysfunction, as pharmacological treatments to restore CFTR function did not normalize the viral response. Both SARS-CoV-2 infection and CFTR function influenced the levels of certain cytokines and chemokines, although these effects were not correlated. Overall, this study reveals a unique viral response in CF epithelial cells, characterized by reduced replication for some viruses like SARS-CoV-2, while showing increased susceptibility to others such as IAV. This research offers a new perspective on CF and viral interactions, emphasizing the need for further investigation into the mechanisms underlying these differences. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
